Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?

被引:3
|
作者
Ferraro, D. [1 ]
Federzoni, L. [1 ]
Vitetta, F. [1 ]
Simone, A. M. [1 ]
Cossarizza, A. [2 ]
Nichelli, P. F. [1 ]
Sola, P. [1 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Neurosci, I-41126 Modena, Italy
[2] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, I-41126 Modena, Italy
关键词
NATALIZUMAB;
D O I
10.1177/1352458513490549
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1550 / 1550
页数:1
相关论文
共 50 条
  • [1] Multiple Sclerosis Relapses Following Cessation of Fingolimod
    Charles B. Malpas
    Izanne Roos
    Sifat Sharmin
    Katherine Buzzard
    Olga Skibina
    Helmut Butzkueven
    Ludwig Kappos
    Francesco Patti
    Raed Alroughani
    Dana Horakova
    Eva Kubala Havrdova
    Guillermo Izquierdo
    Sara Eichau
    Suzanne Hodgkinson
    Pierre Grammond
    Jeannette Lechner-Scott
    Tomas Kalincik
    Clinical Drug Investigation, 2022, 42 : 355 - 364
  • [2] Multiple Sclerosis Relapses Following Cessation of Fingolimod
    Malpas, Charles B.
    Roos, Izanne
    Sharmin, Sifat
    Buzzard, Katherine
    Skibina, Olga
    Butzkueven, Helmut
    Kappos, Ludwig
    Patti, Francesco
    Alroughani, Raed
    Horakova, Dana
    Havrdova, Eva Kubala
    Izquierdo, Guillermo
    Eichau, Sara
    Hodgkinson, Suzanne
    Grammond, Pierre
    Lechner-Scott, Jeannette
    Kalincik, Tomas
    CLINICAL DRUG INVESTIGATION, 2022, 42 (04) : 355 - 364
  • [3] The pathological basis of disability in multiple sclerosis subjects with frequent early relapses
    Nicholas, RS
    Roncaroli, F
    Vora, AJ
    Gentleman, SM
    Graeber, MG
    Malik, O
    Reynolds, RC
    MULTIPLE SCLEROSIS, 2005, 11 : S41 - S42
  • [4] Melanoma during fingolimod treatment for multiple sclerosis
    Velter, C.
    Thomas, M.
    Cavalcanti, A.
    Bastien, M.
    Chochon, F.
    Lubetzki, C.
    Routier, E.
    Robert, C.
    EUROPEAN JOURNAL OF CANCER, 2019, 113 : 75 - 77
  • [5] Frequent early relapses and long-term disease evolution in multiple sclerosis
    Scalfari, A.
    Giannetti, P.
    Neuhaus, A.
    Daumer, M.
    Muraro, P. A.
    Ebers, G.
    JOURNAL OF NEUROLOGY, 2011, 258 : 95 - 95
  • [6] Hypothyroidism in multiple sclerosis patient during fingolimod treatment
    Flores, J.
    Rito, F.
    Torres, G.
    Jung, H.
    Trevino-Frenk, I.
    Corona, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 348 (1-2) : 272 - 273
  • [7] Fingolimod in treatment of multiple sclerosis
    Juszczak, Marek
    Gierach, Pawel
    Glabinski, Andrzej
    AKTUALNOSCI NEUROLOGICZNE, 2010, 10 (03): : 145 - 151
  • [8] Intravenous immunoglobulin treatment in multiple sclerosis - Effect on relapses
    Achiron, A
    Gabbay, U
    Gilad, R
    Hassin-Baer, S
    Barak, Y
    Gornish, M
    Elizur, A
    Goldhammer, Y
    Sarova-Pinhas, I
    NEUROLOGY, 1998, 50 (02) : 398 - 402
  • [9] Frequent early relapses don't always predict severe disability in multiple sclerosis
    Scalfari, A.
    Neuhaus, A.
    Daumer, M.
    Muraro, P. A.
    Ebers, G.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 336 - 336
  • [10] Fingolimod can suppress multiple sclerosis relapses without decreasing serum chemokine levels: implications for relapses after fingolimod discontinuation
    Miyazaki, Y.
    Niino, M.
    Takahashi, E.
    Yamada, M.
    Sato, K.
    Fukazawa, T.
    Fujii, S.
    Amino, I.
    Nakano, F.
    Akimoto, S.
    Minami, N.
    Doi, S.
    Kikuchi, S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 857 - 857